Navigation path

Pharmaceuticals - Union Register


Register of orphan medicinal products


Product information


EU orphan designation number: EU/3/15/1475   
Active ingredient: 1-(4-(N-glycylamido)phenyl)-3-trifluoromethyl-5-(phenanthren-2-yl)-pyrazole-hydrochloride
Indication: Treatment of cryptococcosis
Sponsor: Arno Therapeutics UK, Limited
1 Park Row, Leeds LS1 5AB, United Kingdom

   Public summary of scientific opinion    

European Commission proceduresGoto top of the page

Close date procedure Procedure type EMEA number Decision summary publ decision docs annex
28/04/2015 Orphan designation EMA/OD/300/14 (2015)2939 of 24/04/2015